Angel Invest Boston

Sal's Investment Syndicate: Click to Join Sponsored by: Purdue University entrepreneurship Peter Fasse, patent attorney at Fish & Richardson I invested in Savran Tech back in 2017 around the time of the first part of this interview. Recently I sat down with Cagri Savran to review the progress of his remarkable biotech startup in the last four years. Listen to the original interview followed by a recent update. Here is a list of the topics discussed: Çağrı Savran Bio (Çağrı Is Pronounced Cha-re) Accident that Took Çağrı Savran from Turkey to Indiana Purdue University’s Remarkable Support for the Commercialization of Faculty Inventions Çağrı Savran: “So, when I say "extremely rare," I mean one-in-a-billion rare.” Çağrı Savran: “Our technology can find those five or six or ten cells that are, among about a billion.“ “…from a blood sample, you have a glimpse into the tumor without cutting into the person.” The Promise of Monitoring Cancer Treatment with a Blood Draw “The advantage is if you can do this wit